Minerva Neurosciences (NERV) Reports In-Line Q1 EPS

Minerva Neurosciences (NASDAQ: NERV) reported Q1 EPS of ($0.30), in-line with the analyst estimate of ($0.30).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Lucid reports Q2 output, names new CFO and five other leaders
• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg